The global Lemborexant Tablets market size is predicted to grow from US$ 345 million in 2025 to US$ 462 million in 2031; it is expected to grow at a CAGR of 5.0% from 2025 to 2031.
Lemborexant, sold under the brand name Dayvigo, is an orexin receptor antagonist used to treat insomnia, specifically targeting difficulties with sleep onset and/or maintenance in adults. It is taken orally and works by blocking both OX1 and OX2 orexin receptors, which play a key role in regulating wakefulness.
Common side effects include somnolence, fatigue, headache, and abnormal dreams. Lemborexant has a relatively long elimination half-life, ranging from 17 to 55 hours, with its peak effect occurring about 1 to 3 hours after ingestion. Unlike benzodiazepines or Z-drugs, it does not interact with GABA receptors, offering a different mechanism of action for managing sleep disorders.
Approved for medical use in the United States in December 2019, lemborexant is classified as a Schedule IV controlled substance, indicating a low potential for misuse.
United States market for Lemborexant Tablets is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Lemborexant Tablets is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Lemborexant Tablets is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Lemborexant Tablets players cover Eisai, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Lemborexant Tablets Industry Forecast” looks at past sales and reviews total world Lemborexant Tablets sales in 2024, providing a comprehensive analysis by region and market sector of projected Lemborexant Tablets sales for 2025 through 2031. With Lemborexant Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Lemborexant Tablets industry.
This Insight Report provides a comprehensive analysis of the global Lemborexant Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Lemborexant Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Lemborexant Tablets market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Lemborexant Tablets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Lemborexant Tablets.
This report presents a comprehensive overview, market shares, and growth opportunities of Lemborexant Tablets market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
2.5mg
5 mg
10 mg
Segmentation by Application:
Hospital and Clinic
Retail Pharmacies
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Eisai
Key Questions Addressed in this Report
What is the 10-year outlook for the global Lemborexant Tablets market?
What factors are driving Lemborexant Tablets market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Lemborexant Tablets market opportunities vary by end market size?
How does Lemborexant Tablets break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook